Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hideki FUJINO

Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (3). Foeto-Placental Transfer and Mammary Excretion After Oral Administration in Rats.

Drug Metabolism and Pharmacokinetics

1998

English

Related publications

Studies on the Metabolic Fate of Dilevalol. (II). Absorption, Distribution, Metabolism and Excretion After Repeated Administration to Rats.

Drug Metabolism and Pharmacokinetics

1987

English

Metabolic Fate of Dorzolamide, a New Carbonic Anhydrase Inhibitor. (I): Absorption, Distribution, Metabolism and Excretion of (14C)Dorzolamide After Single Administration to Rats.

Drug Metabolism and Pharmacokinetics

1995

English

Studies on Poisonous Metals. X. Metabolic Fate of Manganese After Oral Administration of Excessive Manganese Chloride in Rats.

Chemical and Pharmaceutical Bulletin

English

Metabolic Fate of Ramosetron Hydrochloride. (2). Absorption, Distribution and Excretion After Oral Administration of 14c-Ramosetron Hydrochloride to Rats.

Drug Metabolism and Pharmacokinetics

1995

English

Studies on the Metabolic Fate of NZ-105. (II). Transfer Into the Fetus and Milk, and Absorption, Distribution, Metabolism and Excretion After Repeated Administration to Rats.

Drug Metabolism and Pharmacokinetics

1991

English

Studies on the Metabolic Fate of Leukotriene Antagonist ONO-1078. (3). Absorption, Distribution and Excretion After Single Administration to Beagle Dogs.

Drug Metabolism and Pharmacokinetics

1993

English

Metabolic Fate of Menaquinone-4 in Dogs. (I). Absorption, Distribution, Metabolism and Excretion After a Single Oral Administration.

Drug Metabolism and Pharmacokinetics

1997

English

NK-104, a Newly Developed HMG-CoA Reductase Inhibitor, Suppresses Neointimal Thickening by Inhibiting Smooth Muscle Cell Growth and Fibronectin Production in Balloon-Injured Rabbit Carotid Artery.

The Japanese Journal of Pharmacology

1998

English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society

2002

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Hideki FUJINO

Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (3). Foeto-Placental Transfer and Mammary Excretion After Oral Administration in Rats.

Related publications

Studies on the Metabolic Fate of Dilevalol. (II). Absorption, Distribution, Metabolism and Excretion After Repeated Administration to Rats.

Metabolic Fate of Dorzolamide, a New Carbonic Anhydrase Inhibitor. (I): Absorption, Distribution, Metabolism and Excretion of (14C)Dorzolamide After Single Administration to Rats.

Studies on Poisonous Metals. X. Metabolic Fate of Manganese After Oral Administration of Excessive Manganese Chloride in Rats.

Metabolic Fate of Ramosetron Hydrochloride. (2). Absorption, Distribution and Excretion After Oral Administration of 14c-Ramosetron Hydrochloride to Rats.

Studies on the Metabolic Fate of NZ-105. (II). Transfer Into the Fetus and Milk, and Absorption, Distribution, Metabolism and Excretion After Repeated Administration to Rats.

Studies on the Metabolic Fate of Leukotriene Antagonist ONO-1078. (3). Absorption, Distribution and Excretion After Single Administration to Beagle Dogs.

Metabolic Fate of Menaquinone-4 in Dogs. (I). Absorption, Distribution, Metabolism and Excretion After a Single Oral Administration.

NK-104, a Newly Developed HMG-CoA Reductase Inhibitor, Suppresses Neointimal Thickening by Inhibiting Smooth Muscle Cell Growth and Fibronectin Production in Balloon-Injured Rabbit Carotid Artery.

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia